#heart disease
Related Stories (3)
Novartis cholesterol setback tests hopes for emerging heart disease drugs - Reuters
Novartis cholesterol setback tests hopes for emerging heart disease drugs Reuters
September 7, 2026FDA panel votes against Capricor's Duchenne heart disease therapy - Reuters
FDA panel votes against Capricor's Duchenne heart disease therapy Reuters
July 29, 2026FDA staff flags concerns about Capricor's Duchenne heart disease therapy - Reuters
FDA staff flags concerns about Capricor's Duchenne heart disease therapy Reuters
July 27, 2026Related Pages (3)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa